(Q43975861)

28 November 2017

Unaltered brain levels of 1,N2-propanodeoxyguanosine adducts of trans-4-hydroxy-2-nonenal in Alzheimer's disease (English)

1 reference

28 November 2017

0 references

M E Götz

1

1 reference

28 November 2017

M Wacker

2

1 reference

28 November 2017

C Luckhaus

3

1 reference

28 November 2017

P Wanek

4

1 reference

28 November 2017

T Tatschner

5

1 reference

28 November 2017

K Jellinger

6

1 reference

28 November 2017

F Leblhuber

7

1 reference

28 November 2017

G Ransmayr

8

1 reference

28 November 2017

P Riederer

9

1 reference

28 November 2017

E Eder

10

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

28 November 2017

1 reference

28 November 2017

324

1 reference

28 November 2017

1

1 reference

28 November 2017

49-52

1 reference

Evolution of neuronal changes in the course of Alzheimer's disease.

28 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900163-5

7 January 2021

Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900163-5

7 January 2021

Oxidative stress: free radical production in neural degeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900163-5

7 January 2021

Repair of propanodeoxyguanosine by nucleotide excision repair in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900163-5

7 January 2021

Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900163-5

7 January 2021

Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900163-5

7 January 2021

The lipid peroxidation by-product 4-hydroxynonenal is toxic to axons and oligodendrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900163-5

7 January 2021

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900163-5

7 January 2021

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900163-5

7 January 2021

The lipid peroxidation product 4-hydroxynonenal inhibits neurite outgrowth, disrupts neuronal microtubules, and modifies cellular tubulin.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900163-5

7 January 2021

4-Hydroxy-2(E)-nonenal inhibits CNS mitochondrial respiration at multiple sites.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900163-5

7 January 2021

Peroxidation of linoleic acid and its relation to aging and age dependent diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900163-5

7 January 2021

In Alzheimer's disease, heme oxygenase is coincident with Alz50, an epitope of tau induced by 4-hydroxy-2-nonenal modification.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900163-5

7 January 2021

Development of a (32)P-postlabeling method for the detection of 1,N(2)-propanodeoxyguanosine adducts of trans-4-hydroxy-2-nonenal in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900163-5

7 January 2021

Detection of 1,N2-propanodeoxyguanosine adducts of trans-4-hydroxy-2-nonenal after gavage of trans-4-hydroxy-2-nonenal or induction of lipid peroxidation with carbon tetrachloride in F344 rats

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900163-5

7 January 2021

Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900163-5

7 January 2021

10.1016/S0304-3940(02)00163-5

Identifiers

DOI

1 reference

28 November 2017

1 reference